Terms: = Cervical cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
96 results:
1. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract] [Full Text] [Related]
2. HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1α/VEGF signaling pathway.
Liu L; Gu K; Hua D
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):132-140. PubMed ID: 38015530
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasound Microvessel Visualization in cervical cancer: Association Between Novel Ultrasound Techniques and Histologic Microvessel Densities.
Zhong J; Huang L; Su M; Wu M; Lin X; Shui X; Jiang Y; Zhang X
Ultrasound Med Biol; 2023 Dec; 49(12):2537-2547. PubMed ID: 37730477
[TBL] [Abstract] [Full Text] [Related]
5. vegfr2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
Zhong J; Su M; Jiang Y; Huang L; Chen Y; Huang Z; Zhang X
J Nanobiotechnology; 2023 Jul; 21(1):220. PubMed ID: 37438780
[TBL] [Abstract] [Full Text] [Related]
6. Design, Synthesis, and Anti-cervical cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives.
Yang Z; Liu ZY; Ablise M; Maimaiti A; Mutalipu Z; Alimujiang Y; Aihaiti A
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299013
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
8. Resveratrol against cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/vegfr2 inhibitors targeting cancer.
El-Khouly OA; Henen MA; El-Sayed MA; El-Messery SM
Sci Rep; 2022 Oct; 12(1):17104. PubMed ID: 36224254
[TBL] [Abstract] [Full Text] [Related]
10. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of cervical cancer in a Subcutaneous Xenograft Mouse Model.
Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
[TBL] [Abstract] [Full Text] [Related]
11. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
Amran N; Abdul-Rahman PS
J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
[TBL] [Abstract] [Full Text] [Related]
12. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
Baeten IGT; Hoogendam JP; Jonges GN; Jürgenliemk-Schulz IM; Braat AJAT; van Diest PJ; Gerestein CG; Zweemer RP
Gynecol Oncol; 2022 May; 165(2):257-263. PubMed ID: 35219527
[TBL] [Abstract] [Full Text] [Related]
13. Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3.
Zhong L; Tang L; He X
Bioengineered; 2022 Feb; 13(2):2971-2980. PubMed ID: 35038961
[TBL] [Abstract] [Full Text] [Related]
14. A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent cervical cancer After Failure of First-Line Therapy.
Yang H; Sun S; Mei Z; Xiang Q; Yang C; Chen M; Xie C; Zhou Y; Qiu H
Drug Des Devel Ther; 2021; 15():4665-4674. PubMed ID: 34815663
[TBL] [Abstract] [Full Text] [Related]
15. Anti-tumour effect of in situ vaccines combined with vegfr inhibitors in the treatment of metastatic cervical cancer.
Liu L; Cai L; Du X; Zhao J; Zhao Y; Zou C; Yu S; Zhang C; Ye P; Su X; Yan X; Li W
Int Immunopharmacol; 2021 Dec; 101(Pt B):108302. PubMed ID: 34717193
[TBL] [Abstract] [Full Text] [Related]
16. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
17. Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L.
Mahnashi MH; Alqahtani YS; Alyami BA; Alqarni AO; Ullah F; Wadood A; Sadiq A; Shareef A; Ayaz M
BMC Complement Med Ther; 2021 Sep; 21(1):239. PubMed ID: 34560864
[TBL] [Abstract] [Full Text] [Related]
18. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced cervical cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract] [Full Text] [Related]
19. Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.
Li Z; Chen C; Liu P; Lu A; Zhao H; Zhan X; Duan H; Li P; Zhao W; Yao J; Li D; Jiang H; Liu M; Bin X; Lang J
Arch Gynecol Obstet; 2022 Feb; 305(2):449-458. PubMed ID: 34406459
[TBL] [Abstract] [Full Text] [Related]
20. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
Regauer S; Reich O; Kashofer K
Am J Surg Pathol; 2022 Feb; 46(2):147-158. PubMed ID: 34387215
[TBL] [Abstract] [Full Text] [Related]
[Next]
